Cargando…

Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model

Objective To investigate the incremental cost effectiveness of two dose human papillomavirus vaccination and of additionally giving a third dose. Design Cost effectiveness study based on a transmission dynamic model of human papillomavirus vaccination. Two dose schedules for bivalent or quadrivalent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jit, Mark, Brisson, Marc, Laprise, Jean-François, Choi, Yoon Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285892/ https://www.ncbi.nlm.nih.gov/pubmed/25567037 http://dx.doi.org/10.1136/bmj.g7584

Ejemplares similares

Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis
por: Prem, Kiesha, et al.
Publicado: (2023)

Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2022)

Now or later: Health impacts of delaying single‐dose HPV vaccine implementation in a high‐burden setting
por: Burger, Emily A., et al.
Publicado: (2022)

Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2023)

From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness
por: Jit, Mark, et al.
Publicado: (2021)

Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution
por: Rungmaitree, Supattra, et al.
Publicado: (2022)

Comparative Cost-Effectiveness Analysis of Two Different Two-Dose Human Papillomavirus Vaccines in Malaysia
por: Kriekinge, Georges Van, et al.
Publicado: (2018)

Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males
por: Bergman, Hanna, et al.
Publicado: (2019)

Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial
por: Wang, Yamin, et al.
Publicado: (2021)

Potential lives saved in 73 countries by adopting multi‐cohort vaccination of 9–14‐year‐old girls against human papillomavirus
por: Jit, Mark, et al.
Publicado: (2018)

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
por: Drolet, Mélanie, et al.
Publicado: (2021)

Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose schedule
por: Germar, Maria Julieta, et al.
Publicado: (2017)

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
por: Jit, Mark, et al.
Publicado: (2011)

Costs of delivering human papillomavirus vaccination using a one- or two-dose strategy in Tanzania
por: Hsiao, Amber, et al.
Publicado: (2023)

Two-dose measles–rubella vaccine schedule for measles–rubella elimination
por: John, T. Jacob
Publicado: (2023)

Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India
por: M de Carvalho, Tiago, et al.
Publicado: (2023)

VIII. Immunological Effectiveness of the Two Dose Schedule
por: Miller, David G., et al.
Publicado: (1962)

Prostate SBRT: Comparison the Efficacy and Toxicity of Two Different Dose Fractionation Schedules
por: Fuller, Donald Blake, et al.
Publicado: (2020)

Persistence of Immunity When Using Different Human Papillomavirus Vaccination Schedules and Booster-Dose Effects 5 Years After Primary Vaccination
por: Lazcano-Ponce, Eduardo, et al.
Publicado: (2019)

Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries
por: Gallagher, Katherine E., et al.
Publicado: (2018)

Vaccine coverage and compliance in Mexico with the two-dose and three-dose rotavirus vaccines
por: Luna-Casas, Gerardo, et al.
Publicado: (2018)

Economic evaluation of human papillomavirus vaccination in the United Kingdom
por: Jit, Mark, et al.
Publicado: (2008)

Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia
por: Brotherton, Julia M.L., et al.
Publicado: (2015)

Optimal vaccine schedules to maintain measles elimination with a two-dose routine policy
por: McKEE, A., et al.
Publicado: (2017)

Comparison of two dosing schedules of intravenous dexmedetomidine in elderly patients during spinal anesthesia
por: Park, Sang Hi, et al.
Publicado: (2014)

Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules
por: Park, Shin-Hyung, et al.
Publicado: (2016)

Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis
por: Brotherton, Julia ML., et al.
Publicado: (2019)

Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic Review
por: Gingras, Guillaume, et al.
Publicado: (2016)

A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial
por: Mackenzie, Grant A., et al.
Publicado: (2022)

Dosing Schedules for Pneumococcal Conjugate Vaccine: Considerations for Policy Makers
por: Whitney, Cynthia G., et al.
Publicado: (2014)

Near-infrared photoimmunotherapy: a comparison of light dosing schedules
por: Ogata, Fusa, et al.
Publicado: (2017)

Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study
por: Abbas, Kaja M, et al.
Publicado: (2020)

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial
por: Watson-Jones, Deborah, et al.
Publicado: (2022)

Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines
por: Lofano, Giuseppe, et al.
Publicado: (2020)

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2022)

Methods for a Systematic Review of Pneumococcal Conjugate Vaccine Dosing Schedules
por: Loo, Jennifer D., et al.
Publicado: (2014)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Immunogenicity
por: Deloria Knoll, Maria, et al.
Publicado: (2014)

Optimal allocation strategies for HPV vaccination introduction and expansion in China accommodated to different supply and dose schedule scenarios: A modelling study
por: You, Tingting, et al.
Publicado: (2022)

Effect of Earlier Vaccination and a Two-Dose Varicella Vaccine Schedule on Varicella Incidence — Beijing Municipality, 2007–2018
por: Zhao, Dan, et al.
Publicado: (2021)

Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule
por: Hoes, Joske, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6p5lpo5vvjq5qnl4f7fgdqrti1